TABLE 2

Regional DV Values After Injection of (+)-11C-McN5652 or 11C-DASB

Radioligand*PonsMBHypoThalamusPutCdFCPCTCCCOCCereb
11C-McN5652
 Control29.4 ± 1.440.2 ± 2.746.1 ± 2.633.4 ± 1.223.6 ± 1.322.0 ± 1.412.9 ± 0.314.4 ± 0.515.5 ± 0.214.9 ± 0.514.3 ± 0.213.7 ± 0.3
 MDMA17.4 ± 1.222.5 ± 2.521.2 ± 2.414.4 ± 0.611.2 ± 0.711.8 ± 0.98.2 ± 0.68.6 ± 0.410.0 ± 0.89.2 ± 0.38.4 ± 0.48.7 ± 0.4
 Paroxetine14.8 ± 3.215.3 ± 2.715.3 ± 2.816.9 ± 3.318.3 ± 3.616.7 ± 3.113.2 ± 2.214.3 ± 2.415.1 ± 1.813.5 ± 2.514.3 ± 2.413.0 ± 2.3
11C-DASB
 Control46.2 ± 11.171.3 ± 14.879.8 ± 11.245.5 ± 4.522.2 ± 3.327.5 ± 2.79.8 ± 1.39.2 ± 1.011.6 ± 1.411.5 ± 1.49.0 ± 0.99.2 ± 0.7
 MDMA26.5 ± 2.731.3 ± 1.431.3 ± 5.615.9 ± 18.9 ± 0.911.5 ± 0.96.1 ± 0.25.9 ± 0.37.2 ± 0.76.9 ± 0.36.0 ± 0.36.3 ± 0.4
 Paroxetine7.7 ± 0.87.9 ± 0.88 ± 0.88.3 ± 0.67.9 ± 0.67.6 ± 0.76.9 ± 0.77.3 ± 0.57.4 ± 0.67.1 ± 0.67.3 ± 0.56.9 ± 0.7
  • * Each radioligand was tested 3 times in control baboon or different baboon lesioned previously with serotonergic neurotoxin MDMA.

  • Designates significant difference from control (ANOVA without correction for multiple comparisons).

  • Designates significant difference from control (ANOVA with correction for multiple comparisons).

  • Designates significant difference from MDMA (ANOVA without correction for multiple comparisons).

  • MB = midbrain; Hypo = hypothalamus; Put = putamen; Cd = caudate; FC = frontal cortex; PC = parietal cortex; TC = temporal cortex; CC = cingulate cortex; OC = occipital cortex; Cereb = cerebellum.

    Values represent mean ± SD (n = 3).